HomeGALE • SWX
Galenica AG
CHF 70.25
May 6, 3:56:29 PM GMT+2 · CHF · SWX · Disclaimer
StockCH listed security
Previous close
CHF 70.55
Day range
CHF 70.15 - CHF 71.00
Year range
CHF 65.10 - CHF 79.45
Market cap
3.51B CHF
Avg Volume
75.08K
P/E ratio
21.25
Dividend yield
3.13%
Primary exchange
SWX
CDP Climate Change Score
C
Market news
Financials
Income Statement
Revenue
Net income
(CHF)Dec 2023Y/Y change
Revenue
948.33M3.46%
Operating expense
59.25M2.34%
Net income
49.18M19.64%
Net profit margin
5.1915.85%
Earnings per share
EBITDA
57.17M8.34%
Effective tax rate
13.46%
Total assets
Total liabilities
(CHF)Dec 2023Y/Y change
Cash and short-term investments
116.16M23.67%
Total assets
2.99B14.47%
Total liabilities
1.52B11.18%
Total equity
1.48B
Shares outstanding
49.83M
Price to book
2.39
Return on assets
4.25%
Return on capital
5.78%
Net change in cash
(CHF)Dec 2023Y/Y change
Net income
49.18M19.64%
Cash from operations
110.37M11.68%
Cash from investing
-31.74M19.52%
Cash from financing
-28.11M-22.72%
Net change in cash
50.42M38.20%
Free cash flow
34.96M-1.11%
About
Galenica AG, headquartered in Bern, is an internationally active Swiss pharmaceutical and logistics company group, named after the ancient physician Galenus. It dates back to the 1927 Collaboration Pharmaceutique SA, a purchasing center for pharmaceutical products founded by 16 pharmacists in Clarens. This was renamed to Galenica AG in 1932 and moved from Vaud's Le Châtelard to Bern. The Galenica shares are listed on the SIX Swiss Exchange and are a component of the SMI MID index. Wikipedia
Founded
1927
Employees
6,181
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu